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Epistaxis is a common clinical condition and in most public 
hospitals these patients received nasal packing and were 
admitted to the hospital as initial management strategies. 
However, little is known about the follow-up of these 
patients after they leave the hospital. Aim: To identify the 
clinical outcome of patients treated for epistaxis following 
discharge. Materials and Methods: We analyzed the results 
of questionnaires from patients hospitalized for non-traumatic 
epistaxis between March 2006 and March 2007. Study design: 
Cohort longitudinal. Results: Fifty-four of eighty-seven 
patients answered (62%). Epistaxis recurred in 37% of the 
patients. Of the patients who had recurrent bleeding, 70% 
were hypertensive, 35% were chronic users of acetylsalicylic 
acid, and 55% used tobacco. Forty per cent of the recurrences 
occurred in the first week after discharge, and fifty per cent 
needed to return to the emergency room. Seventy per cent of 
those who returned to the emergency room required a second 
treatment. Conclusions: Recurrence after epistaxis treatment 
is common and may occur soon after the initial discharge. 
Although our sample was small, this data suggests the need 
for a reevaluation of the current treatment mode of patients 
with epistaxis in the emergency rooms of public hospitals.
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INTRODUCTION
Epistaxis is defined as any bleeding arising from 
the nasal mucosa, it is the most common ENT emergency 
situation1-11, bearing a prevalence of about 10 to 12%1,4,12. 
Its Incidence is of 30 cases for every 100,000 inhabitants, 
and more than 87% of the patients seen by the ENT are 
admitted to a hospital8. This high frequency found is explai-
ned by the rich vascularization of the nose and paranasal 
sinuses, which receive blood supply from the internal and 
external carotid systems12.
Nasal bleeding can be caused by local or systemic 
factors. Among the systemic ones we can mention arterial 
high blood pressure, coagulopathy, blood disorders and 
the use of anticoagulant and anti-platelet adhesion factors. 
The most frequent local factors are: trauma (nasal fractures 
or finger manipulation), upper airway infections, cold and 
dry air breathing, nasal allergies, introduction of foreign 
bodies in the nasal cavity, septal perforation or deviation, 
tumors (juvenile nasoangiofibroma), blood vessel athe-
rosclerosis at the Woodruff plexus and the Osler-Rendu-
Weber disease or systemic telangiectasia2,4,13-15.
There are numerous treatment modalities, which go 
from simple manual compression, cauterization and pa-
cking, all the way to endoscopic or microscopic surgeries2.
The medical emergencies hospital where we car-
ried out this study treats many patients with epistaxis of 
different causes and severity per day. Our routine in this 
public health service, which does not have an endoscopic 
assessment device, is to clean the clots and insert cotton 
balls with vasoconstriction agents followed by digital 
compression. Should the bleeding persist and the bleeding 
spot is not found for cauterization purposes, the nose is 
packed with foam and condom. Hospital admission is 
not a routine for this. Notwithstanding, elderly patients 
or those with uncompensated systemic diseases (e.g.: 
diabetes, hypertension, blood dyscrasia), or with recurrent 
epistaxis of difficult handling at home are treated in the 
hospital setting. Hospitalization time varies and, in some 
cases, hospital stay can be longer than 7 days.
After the bleeding stops, the packing is removed and 
the patient is observed for 12-24 hours. If the bleeding does 
not recur within this period, the patient is discharged and 
instructed to schedule an appointment with a physician 
or public health-care facility in order to be followed up. 
Therefore, we do not have enough information on the 
outcome in regards of the bleeding after hospital discharge. 
The need for further hospital visits and treatment is not 
known. In the literature we also do not have data regarding 
evolution after hospital discharge of those patients who 
were admitted to a hospital because of epistaxis.
This study aims at describing outcomes after hos-
pital discharge of patients who had their noses packed 
and were hospitalized because of non-traumatic epistaxis 
in a public emergency room. More specifically, its aim is 
to check epistaxis recurrence rate, the time span between 
hospital discharge and recurrence and the need for further 
treatment.
MATERIALS AND METHODS
The study was carried out in the department of 
otorhinolaryngology of a medical emergencies public 
hospital between March 2006 and March 2007. It is a his-
torical cohort. All the medical charts from patients with 
non-traumatic epistaxis who received nasal packing and 
were admitted to this hospital were selected as part of 
the sample. 
For data collection purposes, a detailed question-
naire was created, with special attention given to the type 
of treatment provided, hospital stay duration and recur-
rence after hospital discharge (Attachment 1). Through 
the hospital’s data bank we were able to identify those 
patients admitted because of epistaxis during the period 
established. The charts were analyzed, looking for the 
identification data and the details regarding intra-hospital 
care. Afterwards, the patients and their respective guar-
dians were contacted by phone call, and when authorized, 
after reading and signing the informed consent form, we 
employed the questionnaire. For those patients who did 
not have access to a telephone, we mailed an envelope 
with the questionnaire and a stamped envelope for them 
to mail the answers back to us. 
The variables studied included: personal data, 
medical history, use of medication, hospital stays and 
post-hospitalization.
Data processing included the creation of a data bank 
and the analysis was carried out by the SPSS (Statistical 
Package for the Social Sciences) software, version 13.0 
with the help of a statistician.
The quantitative variables were described by the 
average and standard deviation values (symmetrical dis-
tribution) or median and percentiles 25 - 75 (asymmetrical 
distribution). The categorical variables were described by 
means of the absolute and relative frequencies. In order 
to assess the categorical variables in relation to gender, 
recurrence and problem resolution with the new treatment. 
we employed the Pearson’s chi-squared test or Fisher’s 
Exact. In comparing the quantitative variables we used 
the t-Student test for independent samples (symmetrical 
distribution) or the Mann-Whitney test (asymmetrical dis-
tribution). The level of significance adopted was 5%, and 
values of p≤0.05 were considered statistically significant.
This study was approved by the Ethics in Re-
search Committee of our institution, under protocol # 
001.020617.07.5.
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RESULTS
There were losses because of difficulties to contact 
the cases. The initial sample was of 87 patients admitted 
because of non-traumatic epistaxis. We analyzed the 
data from questionnaires answered by 54 patients (62%). 
There was a 38% loss from the initial sample. Of all the 
losses, they happened because of: lack of knowing the 
telephone number and address (27%); because we only 
had the address (70%), did not answer the letters (45% 
from a total of 70%) or because the address was wrong 
(25% from a total of 70%); and one patient who was a 
street dweller (3%).
The mean age of the sample was 60.2 years (stan-
dard deviation of 15.4); with the extremes varying between 
13 and 92 years, and it was more prevalent among males 
(53.7%). In relation to disorders related to a risk increase for 
epistaxis, 68.5% of the patients were hypertensive prior to 
hospital admission, 13% had diabetes, 14.8% had coronary 
disease, 9.3% had psychiatric disorder, 14.8% had COPD, 
3.7% had blood dyscrasia and 25.9% had other diseases. 
Considering chronic use of medication, 31.5% used aspirin, 
9.3% used oral anticoagulants, 14.8% used NSAIDs, 50% 
anti-hypertensive agents and 31.5% used other medication. 
Forty-eight percent of the participants were smokers and 
9.3% drinkers of alcohol, and there was one case of drug 
addition among the patients.
Allergic rhinitis symptoms were prevalent among 
those interviewed; 40.7% of them reported nasal pruritus, 
29.6% reported cluster sneezing; 24.1% nasal obstruction, 
 
Attachment 1 - Data collection spreadsheet
Patient’s Chart Data:
1. Chart number:
2. Name:
3. Age: 4. Gender: 5. Telephone/Address:
6. Profession:
7. Hospitalization duration:
8. Medical history: ( ) High blood pressure ( ) Diabetes ( ) Coronary disease
( ) Psychiatric disorder ( ) Asthma/CPOD ( ) Blood dyscrasia ( ) Other:
9. Use of medication: ( ) Acetyl salicylic acid ( ) Anticoagulant agent
( ) Anti-hypertensive ( )NSAID ( ) other
10. Smoking: ( ) yes ( )no
11. Drinking: ( ) yes ( ) no
12. Use of drugs: ( ) yes ( ) no
13. Habits: ( )nasal pruritus ( )cluster sneezes ( )nasal obstruction
( )chronic use of decongestant nasal drops ( )nasal secretion
14. Past nasal surgeries: ( )yes ( )no
Interview
1. Was the nasal bleeding that caused hospitalization the first episode?
( ) Yes ( ) No
2. How many episodes had happened before? ( ) 1 ( ) 2 ( )3 ( ) 4 ( ) 5 or more
3. Was nasal packing done at the E.R.? ( ) Yes ( ) No
Anterior or posterior?______________________
4. Was nasal cauterization done at the E.R.? ( )Yes ( )No
Chemical or electrical?________________________
5. At the E.R was any other nose intervention done? ( ) Yes ( ) No
6. How long was the hospitalization? ¬¬__________
7. After nasal packing removal and hospital discharge, was there another bleeding?
( ) Yes ( ) No
8. How many? ( )1 ( ) 2 ( ) 3 ( ) 4 ( ) 5 or more?
9. How long after hospital discharge without nasal packing you had another episode?
( ) 1 week or less ( ) 2 weeks ( ) 3 weeks ( ) 1 month
( ) 3 months ( ) 6 months ( ) 1 or + years
10. Did you have to return to the E.R? ( ) Yes ( ) No
11. How many times? ( ) 1 ( ) 2 ( ) 3 ( ) 4 ( ) 5 or more
12. Did you need another treatment? ( ) Yes ( ) No
13. Which? ( ) Cauterization ( ) Surgery ( ) Packing ( ) Embolization ( ) other
14. After this new treatment was the problem solved? ( ) Yes ( ) No
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31.5% had nasal discharge and 14.8% chronically abused 
nasal drops. Thirteen percent of the sample had been 
submitted to nasal surgery before.
Sample characterization according to gender sho-
wed a higher mean age for men (62.5 years) when com-
pared to women (57.5 years). Among men, 65.5% were 
retirees and the remaining 34.5% had jobs, while among 
women, 12% were retirees, 68% worked as volunteers 
and 20%, worked for a salary. Comparing gender and 
occupation regarding the latter data, we found statistically 
significant values, with p<0.001.
Systemic high blood pressure was the most preva-
lent disease associated with epistaxis for both genders, 
present in 72.4% of the men and 64% of the women. Re-
garding the most used medication, antihypertensive agents 
were also the most prevalent in both genders, being used 
by 51.7% of men and 48% of women. Most of the men 
(51.7%) and the women (44%) were smokers. Sixteen 
percent of the women and 10.3% of the men had been 
submitted to nasal surgery in the past. (Table 1)
For 50% of the patients, the hospital bleeding had 
been their first epistaxis episode. Regarding the others, 
16.7% had had only one prior episode of nasal bleeding, 
while 13% had had 2 prior episodes, 5.6% 3 episodes and 
14.8% - 5 or more anterior nasal bleedings prior to the 
hospital admission.
Regarding the nasal packing performed, most of the 
patients (98%) received anterior nasal packing. Anterior 
nasal packing had been done with a piece of foam inside a 
condom and lubricated with neomycin and bacitracin. Pos-
terior nasal packing was carried out with a Foley Catheter.
Hospital stay duration was equivalent for both 
genders, and the epistaxis that caused this admission had 
been the first episode for 55.2% of the men and for 44% 
of the women. The patients with prior history of epistaxis, 
mostly males, had already suffered 5 or more episodes of 
epistaxis prior to the hospital admission (17.2%), while 
among females, most had had only one prior episode 
(20%) (Table 2). As far as treatment is concerned, all the 
men (considering 100 the male gender separately) and 
Table 1. Sample characterization according to gender
Variables  
Total (n=54) Gender
Pd
Men (n=29) Women (n=25)
Age - Mean ± SD 60,2 ± 15,4 62,5 ± 13,2 57,5 ± 17,5 0,234a
Associated disorders - n(%) ... ... ... ...
HBP 37 (68,5) 21 (72,4) 16 (64,0) 0,711b
DM 7 (13) 6 (20,7) 1 (4,0) 0,108c
Coronary disease 8 (14,8) 5 (17,2) 3 (12) 0,711c
Psychiatric disorder 5 (9,3) 2 (6,9) 3 (12) 0,653c
Asthma/CPOD 8 (14,8) 2 (6,9) 6 (24) 0,125c
Blood dyscrasia 2 (3,7) 2 (6,9) 0 (0) 0,493c
Other disorders 14 (25,9) 6 (20,7) 8 (32) 0,526b
Medication - n(%) ... ... ... ...
Aspirin 17 (31,5) 10 (34,5) 7 (28,0) 0,828b
Anticoagulant 5 (9,3) 3 (10,3) 2 (8) 1,000c
Anti-hypertensive agent 27 (50) 15 (51,7) 12 (48) 1,000b
NSAID 8 (14,8) 4 (13,8) 4 (16) 1,000c
Other drugs 17 (31,5) 10 (34,5) 7 (28) 0,828b
Smoking - n(%) 26 (48,1) 15 (51,7) 11 (44) 0,769b
Alcohol abuse - n(%) 5 (9,3) 5 (17,2) 0 (0) 0,054c
Drug addiction - n(%) 0 (0) 0 (0) 0 (0) ...
Past nasal surgery - n(%) 7 (13) 3 (10,3) 4 (16) 0,692c
at-student test for independent samples;
bPearson’s chi-squared test;
cFisher’s Exact Test
dp values mean the statistical difference between men and women for the variables analyzed.
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96% of the women (considering 100% of female gender 
separately) were treated by anterior nasal packing.
Epistaxis recurred in 37% of the patients after hospi-
tal discharge. Of these, all had had anterior nasal packing. 
Of all the women studied, 44% had recurrences, while 
among men this rate was 31%. Recurrence happened only 
once 75% of the cases, there were no important differences 
between the genders (Table 3). Of all the patients with 
epistaxis recurrence, 40% had a new bleeding episode in 
one week or less after hospital discharge (Graph 1).
Fifty-five percent of the patients with epistaxis 
recurrence returned to the E.R because of bleeding, and 
Table 2. Dada regarding hospitalization according to gender
Variables  Total (n=54)
Gender
P
Men (n=29) Women (n=25)
Hospitalization duration - Median (P25 - P75) 3 (2 - 4) 3 (2 - 4) 3 (2 - 4) 0,713a
Epistaxis during hospital stay was the 1st - n(%) 27 (50) 16 (55,2) 11 (44) 0,585b
# of episodes - n(%)c ... ... ... ...
1 prior episode of epistaxis 9 (16,7) 4 (13,8) 5 ( 20) 0,354b
2 prior episodes of epistaxis 7 (13) 4 (13,8) 3 (12) ...
3 prior episodes of epistaxis 3 (5,6) 0 (0,0) 3 (12) ...
4 prior episode of epistaxis 0 (0,0) 0 (0,0) 0 (0,0) ...
>=5 prior episodes of epistaxis 8 (14,8) 5 (17,2) 3 (12) ...
aMann-Whitney test;
bPearson’s chi-squared test;
cOnly for those patients who answered no to the prior question.
Table 3. Post-hospitalization data according to gender
Variables  
Total (n=54) Gender
p
Men(n=29) Women (n=25)
# of relapses (%)a ... ... ... 0,575d
1 recurrence 15 (75) 7 (77,8) 8 (72,7) ...
2 recurrence 1 (5) 0 (0,0) 1 (9,1) ...
3 recurrence 2 (10) 1 (11) 1 (9,1) ...
4 recurrence 1 (5) 1 (11) 0 (0,0) ...
>=5 recurrences 1(5) 0 (0,0) 1 (9,1) ...
# of returns to the E.R. - #(%)b ... ... ... 0,521e
Returned one timea 9 (81,8) 5 (100)  (66,7) ...
Returned 3 times 2 (18,2) 0 (0,0) 2 (33,3) ...
Required another treatment -#(%) 14 (25,9) 8 (27,6) 6 (24) 1,000d
Type of the new treatment #(%)c ... ... ... 0,971d
Cauterization 5 (35,7) 3 (37,5) 2 (33,3) ...
Nasal packing 7 (50) 4 (50,0) 3 (50,0) ...
Surgery 0 (0,0) 0 (0,0) 0 (0,0) ...
Embolization 0 (0,0) 0 (0,0) 0 (0,0) ...
Other 2 (14,3) 1 (12,5) 1 (16,7) ...
New treatment solved the problem #(%)c 10 (71,4) 6 (75) 4 (66,7) 1,000e
aOnly for those patients who had recurrence of the epistaxis.
bOnly for those patients who had to return to the E.R.
cOnly for those patients who required retreatment.
dPearson’s chi-squared test;
eFisher Exact Test
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45% of these patients did not need to return to the hos-
pital emergency ward (p<0.001). Of the patients who did 
return to the hospital emergency ward, 70% required a 
new treatment to control their nasal bleeding, and 30% 
did not (p<0.001). Of the treatment employed, because 
of recurrence, 50% underwent nasal packing, 35.7% were 
submitted to cauterization and 14.3% reported other mo-
des of treatment. None of the patients were submitted to 
surgery or embolization. For 71.4% of the individuals the 
new treatment utilized was definitive (Table 3).
The mean age of the patients with epistaxis recur-
rence was 60.8 years; among those who did not have a 
recurrence, the mean age was 59.9 years. The hospital stay 
duration median value was equivalent for both groups - 3 
days. Of the patients with recurrent epistaxis after hospital 
discharge, 70% were hypertensive and 20% had asthma/
Table 4. Sample characterization according to the recurrence
Variables  
Recurrence
p
Yes (n=20) No (n=34)
Associated disorders - #(%) ... ... ...
HBP 14 (70,0) 23 (67,6) 1,000a
DM 1 (5,0) 6 (17,6) 0,239b
Coronary disease 2 (10,0) 6 (17,6) 0,695b
Psychiatric disease 3 (15,0) 2 (5,9) 0,347b
Asthma/COPD 4 (20,0) 4 (11,8) 0,450b
Blood Dyscrasia 0 (0,0) 2 (5,9) 0,525b
Other diseases 3 (15,0) 11 (32,4) 0,279a
Medication - n(%) ... ... ...
Aspirin 7 (35,0) 10 (29,4) 0,902a
Anticoagulant 2 (10,0) 3 (8,8) 1,000b
Anti-hypertensive 11 (55,0) 16 (47,1) 0,778a
NSAID 3 (15,0) 5 (14,7) 1,000b
Other drugs 6 (30,0) 11 (32,4) 1,000a
Smoking - n(%) 11 (55,0) 15 (44,1) 0,624a
Drinking - n(%) 1 (5,0) 4 (11,8) 0,640b
Drug use - n(%) 0 (0,0) 0 (0,0) ...
AR symptoms - n(%) ... ... ...
Nasal pruritus 8 (40,0) 14 (41,2) 1,000a
Cluster Sneezes 7 (35,0) 9 (26,5) 0,723a
Nasal obstruction 5 (25,0) 8 (23,5) 1,000b
Chronic use of DND 5 (25,0) 3 (8,8) 0,130b
Nasal discharge 6 (30,0) 11 (32,4) 1,000a
Past nasal surgery - n(%) 4 (20,0) 3 (8,8) 0,403b
aPerson’s chi-squared test;
bFisher exact test
Graph 1. Time span between hospital discharge and the first episode 
of recurrence in the sample patients.
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COPD, while among those who did not recur, we found 
67.6% with high blood pressure and 11.8% with asthma/
CPOD. None of the patients with epistaxis recurrence 
had blood dyscrasia. As far as medication is concerned, 
all drugs analyzed had higher prevalence among those 
patients with a new episode of nasal bleeding: 35% used 
aspirin, 10% used anticoagulants, 55% anti-hypertensive 
agents, 15% NSAID and 30% used other medication. 
Fifty-five percent of the patients with recurrence were 
smokers, while 44.1% of those without recurrence were 
smokers. As to the symptoms of allergic rhinitis, there was 
no important difference regarding the occurrence of these 
relapses. Twenty percent of the patients with relapses had 
been previously submitted to nasal surgery, while 8.8% 
of those patients without recurrence had been submitted 
to surgery (Table 4). The bleeding which prompted the 
hospital admission had been the first for 55% of the pa-
tients who had relapses.
DISCUSSION
The present study found a high rate of epistaxis 
recurrence after hospital discharge (37%). Moreover, it 
showed that most of the times the bleeding relapsed in the 
first week after hospital discharge and that about 20% of 
the patients returned to the hospital for another treatment. 
Considering only the patients with epistaxis recurrence, 
55% returned to the emergency room because of bleeding 
and 70% of these required another treatment after this 
recurrence. We do not have literature data to compare 
with the results we found. Nevertheless, although it is a 
small sample - preventing us from doing further statistical 
analyses, 37% seem very significant. Explanations for this 
may stem from numerous factors, especially regarding the 
population making up this sample. Patients admitted for 
epistaxis usually have more severe and resistant signs and 
symptoms when compared to those who are not admit-
ted. Moreover, most of them had systemic disorders and, 
since this is a public hospital, it does not have the proper 
conditions to treat and follow these patients up. Therefore, 
they do not use drugs to control high blood pressure, for 
example, and because of work demands, they can not rest 
enough during the nasal packing period.
Understand the outcomes after treatment provided 
in a health care institution is very important, because 
theoretically, it enables researchers to assess whether the 
treatment used is correct or if it can be improved. We 
observed that for most of the cases which relapsed, ble-
eding occurred in the first week after hospital discharge 
(40%), which challenges the current approach of dischar-
ging the patient 12 to 24 hours after packing removal in 
the institution analyzed. We speculate that if the patients 
were kept longer under observation and in bed rest, these 
recurrence rates could be lower, as well as the need for 
additional treatment. Nevertheless, such problem cannot 
be easily solved because of the lack of bed availability in 
public hospitals and the very need to save these beds for 
more critically ill patients. This is further reinforced by 
the fact that as they return to the emergency ward, a new 
packing solved the problem in 71% of the cases. Often 
times, when the patients returned with epistaxis after re-
cent treatment by nasal packing, surgery was suggested. 
Nonetheless, in the hospital where this study was carried 
out, as it happens in most public hospitals, there is no 
proper material for embolization, nor surgery, and for this 
reason the patients are repacked.
Once the bleeding spot is identified by anterior rhi-
noscopy, vessel cauterization (chemical, electrical or laser 
cauterization) is the first treatment option for epistaxis. 
When such method is not sufficient to control bleeding, the 
patient may require anterior or posterior nasal packing15.
Nasal packing was introduced in the medical prac-
tice by Hippocrates and has been practiced until current 
days as a routine procedure in emergency wards15. Anterior 
nasal cavity packing is less efficient than cauterization, 
since it does not act directly on the bleeding vessel; ho-
wever it applies uniform pressure on the entire mucosa13. 
The edema and inflammatory process resulting from the 
presence of a pack act preventing bleeding15. There are 
many nasal packs available, and the most commonly used 
are those by rayon or gauze. Other alternatives are the 
nasal packs created with glove fingers filled with gauze, 
regular household sponge inside a condom and Merocel 
packing4,14. When bleeding is posterior or when anterior 
nasal packing is not enough, there is a need for posterior 
nasal packing. If the posterior packing is unable to con-
trol bleeding, or if upon its removal in a hospital setting 
after 48-72 hours there is bleeding recurrence, one must 
consider cauterization or endoscopic artery ligation.
Arterial embolization is more often used in nasal 
vascular tumors, such as the juvenile nasoangiofibroma, 
in the preoperative period, in order to reduce tumoral 
nasal flow during surgery. It can also be used in severe 
and persistent epistaxis which does not respond to clinical 
treatment4,16-18.
Nasal packing with a foam piece inside a condom, 
or even a glove finger, is the most used method in most 
of the centers dealing with epistaxis2,7,14-15. It is a fast and 
easy treatment mode, and it is inexpensive - essential 
aspect of medical care in a public hospital setting. The 
duration of nasal packing is not absolutely defined in the 
literature; nonetheless, most ENTs leave it for at least 48 
hours2,4,14-15. It does not seem to us that the premature 
nasal packing removal has been the cause for this high 
recurrence rate, but rather the factors discussed in the 
first paragraph (patients with more severe and clinically 
decompensated epistaxis). The treatment provided by the 
hospital of our study for inpatients with epistaxis is to keep 
them packed and in absolute bed rest until the bleeding 
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subsides. Then, the packing is removed and the patient 
is discharged within 12 to 24 hours. This may be a factor 
to be considered. Another issue reported by this study is 
the need to invest in endoscopic surgery equipment. Since 
20% of the cases return to the emergency room and need 
retreatment, including hospitalization. Surgery could, in the 
middle run, represent major savings for the public sector, 
knowing of its greater resolution power and lesser need 
for hospitalization time1,11,16-20.
Median hospitalization duration for the patients in 
our sample was 3 days, matching information found in 
the literature3,21. The epistaxis episode during hospital stay 
was the first in 50% of the patients. We do not have data 
in the literature to compare ours with.
Epistaxis has a bimodal distribution in relation to 
age, with the first incidence peak during childhood and 
the next around 50 years and on3,13-14. We believe our study 
has shown only one peak involving elderly patients, be-
cause of the hospital stay factor which results from more 
severe epistaxis, usually due to systemic diseases - more 
prevalent in older individuals.
By our statistical analyses of the sample evaluated, 
we did not find differences between the patients with and 
without epistaxis recurrence; nonetheless, these results 
have to be interpreted very carefully, because of the small 
sample and consequently its small statistical power. Howe-
ver, some observations still apply. Sixty-nine percent of the 
patients in this sample were hypertensive. The literature 
shows a clear association between high blood pressure 
and epistaxis5; however, the cause and effect relationship 
is chalenged22. Other two risk factors for epistaxis which 
had high rates in this sample were smoking (48%) and 
the use of aspirin (31%). Literature shows that there is an 
association between the use of aspirin and epistaxis4,13-15, 
and the risk of nasal bleeding increases in approximately 
two fold in those patients using such medication22. As far 
as smoking is concerned, it is mentioned as a risk factor 
for severe epistaxis23. The symptoms associated with 
allergic rhinitis presented high incidence in this sample, 
especially nasal pruritus (41%). Epistaxis can be triggered 
by itching, blowing the nose, coughing, sneezing, the 
use of decongestant nasal drops - factors are associated 
to nasal allergies4,13-15.
Many can be the reasons for the high incidence seen 
with the technique used in our sample, one of them is that 
these more severely ill patients come to the emergency 
service and require hospitalization to treat not only the 
bleeding, but also comorbidities. Another aspect is that the 
condom with the foam piece inside (or sponge) usually 
fills better the lowermost portions of the nasal cavity. Some 
patients, in whom the bleeding comes from the upper nose 
may not have successful outcomes by this approach. And 
finally, we can speculate that the time required to remove 
the packing was too early. 
One systematic mistake identified in this study ha-
ppened in relation to the follow up time. The time between 
hospitalization and the patient’s interview was not factored, 
in other words, interviewed patients in a longer period 
of time after the hospitalization epistaxis have a greater 
risk of recurrences in relation to our interviewees in less 
time. Another issue that must be highlighted associated 
with sample losses is the location of some cases and the 
response in others. These represented a major difficulty in 
this study, present at two moments: first, because of the 
lack of data that could allow patient access (telephone, 
address) in the medical charts; and at a second time, by 
the lack of individual interest in cooperating with the stu-
dy, not answering the mail containing the questionnaire.
CONCLUSION
The recurrence rate of non-traumatic epistaxis in 
patients who were packed and hospitalized in a public 
hospital of medical emergencies was 37%. The time span 
between discharge and recurrence in most of the cases 
happened in the first week after hospital discharge (40% 
of the cases) and about 20% of the cases returned to the 
emergency room for reassessment and treatment. Despite 
the sample being small, these data require a reassessment 
of the current model of epistaxis management in most 
public hospitals.
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